NEW YORK--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced that it has called an extraordinary general meeting of its shareholders (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback